Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.

Gynecologic oncology - 1 May 2005

Spillman Monique A, Schildkraut Joellen M, Halabi Susan, Moorman Patricia, Calingaert Brian, Bentley Rex C, Marks Jeffrey R, Murphy Susan, Berchuck Andrew

Abstract excerpt

OBJECTIVES: It has been suggested that the 6A allele of the type I TGFbeta receptor (TGFbetaR1) polyalanine repeat tract polymorphism may increase susceptibility to various types of cancer including ovarian cancer. METHODS: The TGFbetaR1 polyalanine polymorphism was genotyped in 588 ovarian cancer cases and 614 controls from a population-based case-control study in North Carolina. RESULTS: Significant racial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to North Carolina

Share to Ovarian Neoplasms

Share to Peptides

Share to Polymorphism, Genetic

Share to Receptors, Transforming Growth Factor beta

Share to Repetitive Sequences, Amino Acid

Source

Identifiers

PMID: 15863158
DOI: 10.1016/j.ygyno.2005.01.025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.PMID 15863158Read ↗

Uncommon TGFBRI allele is not associated with increased susceptibility to colon cancer.Semantic proximity Read ↗

Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.Semantic proximity Read ↗

TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk.Semantic proximity Read ↗

The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.Semantic proximity Read ↗

The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.Semantic proximity Read ↗

The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.Semantic proximity Read ↗

Genetic variations of the A13/A14 repeat located within the EGFR 3' untranslated region have no oncogenic effect in patients with colorectal cancer.Semantic proximity Read ↗

No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.Semantic proximity Read ↗

The prohibitin 3' untranslated region polymorphism is not associated with risk of ovarian cancer.Semantic proximity Read ↗

The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer.Semantic proximity Read ↗

Ha-ras polymorphisms in epithelial ovarian cancer.Semantic proximity Read ↗

The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.